Seminars in Oncology
Volume 34, Issue 2 , Pages 110-121, April 2007

Radical Cystectomy and Lymphadenectomy for Invasive Bladder Cancer: Towards the Evolution of an Optimal Surgical Standard

  • Ganesh V. Raj
  • ,
  • Bernard H. Bochner

      Affiliations

    • Corresponding Author InformationAddress correspondence to Bernard H. Bochner, MD, Memorial Sloan-Kettering Cancer Center, Department of Urology, Kimmel Center for Prostate and Urologic Diseases, 353 E 68th St, New York, NY 10021.

Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY.

The surgical management of invasive bladder cancer has undergone a significant evolution in technique since its initial introduction. Changes in the extent of surgery have largely reflected a better understanding of the natural history of bladder cancer and the recognized pathways of progression. Incorporation of contemporary surgical techniques that target the perivesical soft tissues, regional lymph nodes, and adjacent organs appear to enhance oncologic outcomes. A growing body of evidence indicates that the quality of radical cystectomy (RC) directly affects patient outcome. Recently, quality of life and functional considerations have led to surgical modifications such as nerve-, prostate-, vaginal wall–, and urethra-sparing approaches. While some modifications in appropriate candidates appear not to decrease cancer control, further studies will be needed to establish their role and safety. This ongoing evolution in the technique of RC and pelvic lymph node dissection (PLND) may help define a new surgical standard that provides optimal benefit in patients with invasive bladder cancer.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(06)00488-X

doi:10.1053/j.seminoncol.2006.12.011

Seminars in Oncology
Volume 34, Issue 2 , Pages 110-121, April 2007